메뉴 건너뛰기




Volumn 17, Issue 1, 2017, Pages

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis

Author keywords

Antimicrobial resistance; Enterobacteriaceae; Hospital cost; Hospital mortality; Inappropriate empiric therapy; Pneumonia; Sepsis; UTI

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

EID: 85018470884     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2383-z     Document Type: Article
Times cited : (178)

References (43)
  • 1
    • 84986598004 scopus 로고    scopus 로고
    • National Nosocomial Infections Surveillance (NNIS) System Report
    • National Nosocomial Infections Surveillance (NNIS) System Report. Am J Infect Control. 2004;32:470. https://www.cdc.gov/nhsn/pdfs/datastat/nnis_2004.pdf.
    • (2004) Am J Infect Control. , vol.32 , pp. 470
  • 2
    • 9644274002 scopus 로고    scopus 로고
    • National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002
    • Obritsch MD, Fish DN, MacLaren R, Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother. 2004;48:4606-10.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 4606-4610
    • Obritsch, M.D.1    Fish, D.N.2    MacLaren, R.3    Jung, R.4
  • 3
    • 34948846090 scopus 로고    scopus 로고
    • Health care-associated pneumonia and community-acquired pneumonia: a single-center experience
    • Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51:3568-73.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3568-3573
    • Micek, S.T.1    Kollef, K.E.2    Reichley, R.M.3
  • 4
    • 0036304245 scopus 로고    scopus 로고
    • Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia
    • Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122:262-8.
    • (2002) Chest , vol.122 , pp. 262-268
    • Iregui, M.1    Ward, S.2    Sherman, G.3
  • 5
    • 9344239309 scopus 로고    scopus 로고
    • Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    • Alvarez-Lerma F, ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 1996;22:387-94.
    • (1996) Intensive Care Med , vol.22 , pp. 387-394
    • Alvarez-Lerma, F.1
  • 6
    • 55849092085 scopus 로고    scopus 로고
    • Antimicrobial therapy escalation and hospital mortality among patients with HCAP: a single center experience
    • Zilberberg MD, Shorr AF, Micek MT, Mody SH, Kollef MH. Antimicrobial therapy escalation and hospital mortality among patients with HCAP: a single center experience. Chest. 2008;134:963-8.
    • (2008) Chest , vol.134 , pp. 963-968
    • Zilberberg, M.D.1    Shorr, A.F.2    Micek, M.T.3    Mody, S.H.4    Kollef, M.H.5
  • 9
    • 0032911760 scopus 로고    scopus 로고
    • Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients
    • Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-74.
    • (1999) Chest , vol.115 , pp. 462-474
    • Kollef, M.H.1    Sherman, G.2    Ward, S.3    Fraser, V.J.4
  • 11
    • 0242266613 scopus 로고    scopus 로고
    • Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    • Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529-35.
    • (2003) Am J Med , vol.115 , pp. 529-535
    • Harbarth, S.1    Garbino, J.2    Pugin, J.3    Romand, J.A.4    Lew, D.5    Pittet, D.6
  • 13
    • 84870946642 scopus 로고    scopus 로고
    • Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
    • Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34:1-14.
    • (2013) Infect Control Hosp Epidemiol , vol.34 , pp. 1-14
    • Sievert, D.M.1    Ricks, P.2    Edwards, J.R.3    Schneider, A.4    Patel, J.5    Srinivasan, A.6    Kallen, A.7    Limbago, B.8    Fridkin, S.9
  • 14
    • 84926343938 scopus 로고    scopus 로고
    • Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in gram-negative severe sepsis and septic shock: a retrospective cohort study
    • Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596.
    • (2014) Crit Care , vol.18 , Issue.6 , pp. 596
    • Zilberberg, M.D.1    Shorr, A.F.2    Micek, S.T.3    Vazquez-Guillamet, C.4    Kollef, M.H.5
  • 15
    • 84884597711 scopus 로고    scopus 로고
    • Antibiotic Resistance Threats in the United States
    • Accessed 29 May 2014.
    • Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Available at https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed 29 May 2014.
    • (2013)
  • 16
    • 30344451643 scopus 로고    scopus 로고
    • Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia
    • Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854-62.
    • (2005) Chest , vol.128 , pp. 3854-3862
    • Kollef, M.H.1    Shorr, A.2    Tabak, Y.P.3
  • 17
    • 13644269309 scopus 로고    scopus 로고
    • Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia
    • Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 388-416
  • 18
    • 84873339299 scopus 로고    scopus 로고
    • Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012
    • Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
    • (2013) Crit Care Med , vol.41 , pp. 580-637
    • Dellinger, R.P.1    Levy, M.M.2    Rhodes, A.3
  • 19
    • 84881139580 scopus 로고    scopus 로고
    • Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009
    • Zilberberg MD, Shorr AF. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infect Control Hosp Epidemiol. 2013;34:940-6.
    • (2013) Infect Control Hosp Epidemiol , vol.34 , pp. 940-946
    • Zilberberg, M.D.1    Shorr, A.F.2
  • 22
    • 84987700959 scopus 로고    scopus 로고
    • Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
    • Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis. Crit Care. 2016 Jul 11;20:221.
    • (2016) Crit Care , vol.20 , pp. 221
    • Zilberberg, M.D.1    Nathanson, B.H.2    Sulham, K.3    Fan, W.4    Shorr, A.F.5
  • 23
    • 77952215380 scopus 로고    scopus 로고
    • Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy
    • Meddings J, Saint S, McMahon LF. Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy. Infect Control Hosp Epidemiol. 2010;31:627-33.
    • (2010) Infect Control Hosp Epidemiol , vol.31 , pp. 627-633
    • Meddings, J.1    Saint, S.2    McMahon, L.F.3
  • 27
    • 0037451929 scopus 로고    scopus 로고
    • The epidemiology of sepsis in the United States from 1979 through 2000
    • Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.
    • (2003) N Engl J Med , vol.348 , pp. 1546-1554
    • Martin, G.S.1    Mannino, D.M.2    Eaton, S.3    Moss, M.4
  • 28
    • 0033918632 scopus 로고    scopus 로고
    • A note on robust variance estimation for cluster-correlated data
    • Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-6.
    • (2000) Biometrics , vol.56 , pp. 645-646
    • Williams, R.L.1
  • 29
    • 84874894245 scopus 로고    scopus 로고
    • Vital signs: carbapenem-resistant enterobacteriaceae
    • Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62:165-70.
    • (2013) MMWR Morb Mortal Wkly Rep , vol.62 , pp. 165-170
  • 30
    • 84873643362 scopus 로고    scopus 로고
    • Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010
    • Braykov NP, Eber MR, Klein EY, Morgan DJ, Laxminarayan R. Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010. Infect Control Hosp Epidemiol. 2013;34:259-68.
    • (2013) Infect Control Hosp Epidemiol , vol.34 , pp. 259-268
    • Braykov, N.P.1    Eber, M.R.2    Klein, E.Y.3    Morgan, D.J.4    Laxminarayan, R.5
  • 31
    • 84885187601 scopus 로고    scopus 로고
    • Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009
    • Zilberberg MD, Shorr AF. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. J Hosp Med. 2013;8:559-63.
    • (2013) J Hosp Med , vol.8 , pp. 559-563
    • Zilberberg, M.D.1    Shorr, A.F.2
  • 32
    • 84888990813 scopus 로고    scopus 로고
    • Emerging infections program-active bacterial Core surveillance MRSA surveillance investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011
    • Dantes R, Mu Y, Belflower R, et al. Emerging infections program-active bacterial Core surveillance MRSA surveillance investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173:1970-8.
    • (2013) JAMA Intern Med , vol.173 , pp. 1970-1978
    • Dantes, R.1    Mu, Y.2    Belflower, R.3
  • 33
    • 84923775846 scopus 로고    scopus 로고
    • Burden of Clostridium difficile infection in the United States
    • Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825-34.
    • (2015) N Engl J Med , vol.372 , pp. 825-834
    • Lessa, F.C.1    Mu, Y.2    Bamberg, W.M.3
  • 35
    • 84944144997 scopus 로고    scopus 로고
    • Epidemiology of Carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013
    • Guh AY, Bulens SN, Mu Y, et al. Epidemiology of Carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013. JAMA. 2015;314:1479-87.
    • (2015) JAMA , vol.314 , pp. 1479-1487
    • Guh, A.Y.1    Bulens, S.N.2    Mu, Y.3
  • 36
    • 84962191050 scopus 로고    scopus 로고
    • Clinical significance of community- and healthcare-acquired Carbapenem-resistant Enterobacteriaceae isolates
    • Tang HJ, Hsieh CF, Chang PC, Chen JJ, Lin YH, Lai CC, Chao CM, Chuang YC. Clinical significance of community- and healthcare-acquired Carbapenem-resistant Enterobacteriaceae isolates. PLoS One. 2016;11(3):e0151897.
    • (2016) PLoS One , vol.11 , Issue.3
    • Tang, H.J.1    Hsieh, C.F.2    Chang, P.C.3    Chen, J.J.4    Lin, Y.H.5    Lai, C.C.6    Chao, C.M.7    Chuang, Y.C.8
  • 37
    • 84873638279 scopus 로고    scopus 로고
    • Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States
    • Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56:641-8.
    • (2013) Clin Infect Dis , vol.56 , pp. 641-648
    • Doi, Y.1    Park, Y.S.2    Rivera, J.I.3
  • 38
    • 24044511840 scopus 로고    scopus 로고
    • Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
    • Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52-9.
    • (2005) J Antimicrob Chemother , vol.56 , pp. 52-59
    • Pitout, J.D.1    Nordmann, P.2    Laupland, K.B.3    Poirel, L.4
  • 39
    • 62549151316 scopus 로고    scopus 로고
    • Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection
    • Rodríguez-Baño J, Alcalá J, Cisneros JM, et al. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother. 2009;63:781-4.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 781-784
    • Rodríguez-Baño, J.1    Alcalá, J.2    Cisneros, J.M.3
  • 40
    • 84881129503 scopus 로고    scopus 로고
    • Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community
    • Banerjee R, Strahilevitz J, Johnson JR, et al. Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol. 2013;34:947-53.
    • (2013) Infect Control Hosp Epidemiol , vol.34 , pp. 947-953
    • Banerjee, R.1    Strahilevitz, J.2    Johnson, J.R.3
  • 41
    • 49949084009 scopus 로고    scopus 로고
    • Inappropriate therapy for methicillin-resistant Staphylococcus Aureus: resource utilization and cost implications
    • Shorr AF, Micek ST, Kollef MH. Inappropriate therapy for methicillin-resistant Staphylococcus Aureus: resource utilization and cost implications. Crit Care Med. 2008;36:2335-40.
    • (2008) Crit Care Med , vol.36 , pp. 2335-2340
    • Shorr, A.F.1    Micek, S.T.2    Kollef, M.H.3
  • 42
    • 84879464642 scopus 로고    scopus 로고
    • Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011
    • Bouchillon SK, Badal RE, Hoban DJ, Hawser SP. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011. Clin Ther. 2013;35:872-7.
    • (2013) Clin Ther , vol.35 , pp. 872-877
    • Bouchillon, S.K.1    Badal, R.E.2    Hoban, D.J.3    Hawser, S.P.4
  • 43
    • 84888857844 scopus 로고    scopus 로고
    • Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011
    • Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Hackel MA, Biedenbach DJ, Goff DA. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011. J Inf Secur. 2014;68:71-6.
    • (2014) J Inf Secur , vol.68 , pp. 71-76
    • Hawser, S.P.1    Badal, R.E.2    Bouchillon, S.K.3    Hoban, D.J.4    Hackel, M.A.5    Biedenbach, D.J.6    Goff, D.A.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.